Literature DB >> 12531993

Neuroscience. Deconstructing schizophrenia.

Constance Holden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531993     DOI: 10.1126/science.299.5605.333

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

Review 1.  The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.

Authors:  Corinne Beinat; Samuel D Banister; Marco Herrera; Vivian Law; Michael Kassiou
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

2.  Schizophrenia-related neuregulin-1 single-nucleotide polymorphisms lead to deficient smooth eye pursuit in a large sample of young men.

Authors:  Nikolaos Smyrnis; Emmanouil Kattoulas; Nicholas C Stefanis; Dimitrios Avramopoulos; Costas N Stefanis; Ioannis Evdokimidis
Journal:  Schizophr Bull       Date:  2009-12-04       Impact factor: 9.306

3.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

4.  TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.

Authors:  T A Hauser; A Kucinski; K G Jordan; G J Gatto; S R Wersinger; R A Hesse; E K Stachowiak; M K Stachowiak; R L Papke; P M Lippiello; M Bencherif
Journal:  Biochem Pharmacol       Date:  2009-05-29       Impact factor: 5.858

5.  Glutamatergic ionotropic blockade within accumbens disrupts working memory and might alter the endocytic machinery in rat accumbens and prefrontal cortex.

Authors:  G Baiardi; A M Ruiz; A Beling; J Borgonovo; G Martínez; A I Landa; M A Sosa; P A Gargiulo
Journal:  J Neural Transm (Vienna)       Date:  2007-07-10       Impact factor: 3.575

6.  Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways.

Authors:  Emanuel Schwarz; Nico J M van Beveren; Jordan Ramsey; F Markus Leweke; Matthias Rothermundt; Bernhard Bogerts; Johann Steiner; Paul C Guest; Sabine Bahn
Journal:  Schizophr Bull       Date:  2013-08-09       Impact factor: 9.306

7.  A structure-function mechanism for schizophrenia.

Authors:  Kunjumon I Vadakkan
Journal:  Front Psychiatry       Date:  2012-12-28       Impact factor: 4.157

8.  Possible effects of synaptic imbalances on oligodendrocyte-axonic interactions in schizophrenia: a hypothetical model.

Authors:  Bernhard J Mitterauer; Birgitta Kofler-Westergren
Journal:  Front Psychiatry       Date:  2011-04-12       Impact factor: 4.157

9.  Neurophysiological correlates of configural face processing in schizotypy.

Authors:  Rachel A Batty; Andrew J P Francis; Hamish Innes-Brown; Nicole R Joshua; Susan L Rossell
Journal:  Front Psychiatry       Date:  2014-08-12       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.